Modulation of chondrogenesis by DG11 (Genkwadaphnin) in clonal mouse embryonic ATDC5 cells.

ABSTRACT: Endochondral bone formation occurs when mesenchymall cells condense to differentiate into chondrocytes- the primary cell types of cartilage. To identify novel factors that are involved in the control of chondrogensis, we investigated the role of DG 11 to induce chondrogenic diffeerentitat...

Full description

Saved in:
Bibliographic Details
Main Author: Nepal, Manoj
Format: Unknown
Language:English
Published: c2010.
Subjects:
Online Access:Visit NHRC Library
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01938 a2200265 4500
003 OSt
005 20220906184551.0
008 191115b ||||| |||| 00| 0 eng d
952 |0 0  |1 0  |2 NLM  |4 0  |6 THS_00233_NEP_2010_000000000000000  |7 0  |9 710  |a NHRC  |b NHRC  |d 2012-07-26  |l 0  |o THS-00233/NEP/2010  |p THS-00233  |r 2012-07-26  |w 2012-07-26  |y TR 
999 |c 704  |d 704 
060 |a THS-00233 
100 |a Nepal, Manoj.  |9 1757 
245 |a Modulation of chondrogenesis by DG11 (Genkwadaphnin) in clonal mouse embryonic ATDC5 cells. 
260 |c c2010. 
300 |a ii, 38p. : 
500 |a Thesis Report. 
520 |a ABSTRACT: Endochondral bone formation occurs when mesenchymall cells condense to differentiate into chondrocytes- the primary cell types of cartilage. To identify novel factors that are involved in the control of chondrogensis, we investigated the role of DG 11 to induce chondrogenic diffeerentitation of ATDC5 cells. Accumulation of fcartilage nodules due to chondrocytes differentiation and expression of different chondrocyte- specific gene markers such as type 11 collagen, type X collagen, aggrecan, Sox9, Runx2 and Osterix was observed upon treatment of ATDC5 cells with DG11 in conecentration and time dependent manners. Furthermore, phosphorylation of ERK and JNK but not that of p38 MAP kinase reveals stimulatory effect of DG11 for chondrogenic differentiation. Conversely, induction of chondrogenesis was significantly suppressed by treating ATDC5 cells with PD98059 and SP 600125, potent inhibitors of ERK and JNK MAP kinase, respectively. From the above findings, we assumed the possible therapeutic effect of DG11 against various growth disorders such as dwarfism. 
546 |a Eng. 
650 |a Modulation.  |9 2814 
650 |a Chondrogenesis.  |9 2815 
650 |a DG11 .  |9 2816 
650 |a Clonal mouse.  |9 2817 
650 |a ATDC5 cells.  |9 2818 
856 |u http://nhrc.gov.np/contact/  |y Visit NHRC Library  
942 |2 NLM  |c TR